Supportive care of patients with fibrosing interstitial lung disease: answering a great clinical need.
Supportive care of patients with fibrosing interstitial lung disease: answering a great clinical need.
复制标题
DOI：
10.1183/20734735.0066-2020
复制
发表时间：
2020-09
期刊：
影响因子：
--
通讯作者：
Saini G
中科院分区：
文献类型：
--
作者：
Goodwin AT;Saini G
纤维化间质性肺疾病（f - ild）是一个异质性的群体，包括特发性肺纤维化（IPF）、结缔组织病相关的间质性肺疾病、过敏性肺炎和石棉肺等。所有f - ild的共同特征是疤痕组织不可逆转地取代正常肺实质，导致气体交换受损，最终导致呼吸衰竭。纤维化间质性肺病（F-ILD）显著降低生活质量。F-ILD的护理包括症状管理，临终计划和支持措施，以及抗纤维化药物。患者和护理人员应该是所有护理决策的中心。https://bit.ly/2ZAE2Ks
The fibrosing interstitial lung diseases (F-ILDs) are a heterogeneous group, including idiopathic pulmonary fibrosis (IPF), connective tissue disease-associated interstitial lung disease, hypersensitivity pneumonitis and asbestosis, among others. The common feature of all F-ILDs is the irreversible replacement of normal lung parenchyma with scar tissue, resulting in impaired gas exchange and culminating in respiratory failure. Fibrosing interstitial lung disease (F-ILD) significantly reduces quality of life. F-ILD care includes symptom management, end-of-life planning and supportive measures, as well as antifibrotics. Patients and carers should be central to all care decisions. https://bit.ly/2ZAE2Ks